TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/26/22 16:15 | 10/20/22 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Atillasoy Ercem | MA | O | See Rema | S.am | -18 | 8.72 | 0 | -2 | -2 | 131 | D | ||||||||||||||
10/24/22 18:23 | 10/19/22 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Atillasoy Ercem | MA | O | See Rema | S.m | -18 | 8.72 | 0 | -2 | -2 | 131 | D | ||||||||||||||
7/22/22 16:22 | 7/21/22 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Atillasoy Ercem | MA | O | See Rema | S | -8 | 5.38 | 0 | -2 | -1 | 133 | D | ||||||||||||||
7/21/22 19:11 | 7/20/22 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Atillasoy Ercem | MA | O | See Rema | S | -3 | 5.21 | 0 | -1 | 0 | 135 | D | ||||||||||||||
4/22/22 08:23 | 4/20/22 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Atillasoy Ercem | MA | O | See Rema | S.m | -12 | 6.04 | 0 | -2 | -2 | 122 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |